None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - advanced solid cancer who will receive palliative 1st line chemotherapy - Eastern Cooperative Oncology Group performance status of 0-2 - life expectancy >=4 months - normal liver, kidney function - who can comply study protocol
Exclusion criteria
Exclusion criteria: - pregnant of lactating women - brain metastases - bone metastases with risk of pathologic fracture - COPD GOLD stage >=3, anticoaguant treatment - megestrol acetate treatment - musculoskeletal disease - uncontrolled hypertension - symptomatic congestive heart failure - arrhythmia or acute myocardial infarction in recent 6 months - dementia or other psychiatric/neurologic disorder who cannot understand informed consent - uncontrolled severe infection of other concomitant disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of Life (EORTC QLQ-C30) | — |
Secondary
| Measure | Time frame |
|---|---|
| Change of skeletal muscle;grip power;funcitonal capicity (6m test);adverse event | — |
Countries
Korea, Republic of
Contacts
Gachon University Gil Medical Center